Curia Invests $28 Million in Sterile API Manufacturing
8 Articles
8 Articles
Curia Invests $28 Million in Sterile API Manufacturing
ALBANY, N.Y., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), a leading global contract, development and manufacturing organization (CDMO), today announced a strategic investment to expand its sterile API manufacturing capabilities for both steroid and non-steroid products in…
Curia Invests $28 Million to Expand Sterile API Manufacturing in Spain
Curia Global is investing $28 million to expand sterile active pharmaceutical ingredient manufacturing at its Valladolid, Spain, facility, increasing capacity... The post Curia Invests $28 Million to Expand Sterile API Manufacturing in Spain appeared first on citybiz.
Curia Invests $28 Million in Sterile API Manufacturing - Swaziland Online News
ALBANY, N.Y., Oct. 05, 2026 (GLOBE NEWSWIRE) — Curia Global, Inc. (Curia), a leading global contract, development and manufacturing organization (CDMO), today announced a strategic investment to expand its sterile API manufacturing capabilities for both steroid and non-steroid products in Valladolid, Spain. This expansion is set to be completed in the fourth quarter of 2028. […]
Curia Melabur AS$28 Juta dalam Pengeluaran API Steril
ALBANY, N.Y., Oct. 05, 2026 (GLOBE NEWSWIRE) — Curia Global, Inc. (Curia), sebuah organisasi pembangunan dan pengilangan kontrak (CDMO) terkemuka di peringkat global, hari ini mengumumkan pelaburan strategik untuk memperluas keupayaan pengilangan API steril bagi produk steroid dan bukan steroid di Valladolid, Sepanyol. Peluasan ini dijangka siap pada suku keempat tahun 2028. Digabungkan dengan jaminan […] The post Curia Melabur AS$28 Juta dalam …
ALBANY, N.Y., Oct. 05, 2026 (GLOBE NEWSWIRE) — Curia Global, Inc. (Curia), one of the world's leading contract-based manufacturing and development services (CDMO) providers, today announced an investment in...
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium










